U
Vaxxinity, Inc. VAXX
$0.0002 -$0.0153-98.71% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income -56.93M -66.00M -72.11M -75.38M -75.22M
Total Depreciation and Amortization 2.23M 2.32M 2.07M 1.94M 1.68M
Total Amortization of Deferred Charges 51.00K 52.00K 52.00K 52.00K 53.00K
Total Other Non-Cash Items 5.95M 7.00M 7.52M 7.38M 7.74M
Change in Net Operating Assets -8.54M -3.24M 4.38M 9.55M 9.82M
Cash from Operations -57.24M -59.87M -58.09M -56.47M -55.93M
Capital Expenditure -803.00K -681.00K -876.00K -1.33M -1.87M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 29.65M 57.14M -16.91M -43.61M -52.53M
Cash from Investing 28.84M 56.46M -17.79M -44.94M -54.39M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -1.59M -1.39M -1.06M -900.00K -430.00K
Issuance of Common Stock 454.00K 454.00K 427.00K 146.00K 263.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 0.00 0.00 -1.00K --
Cash from Financing -1.14M -936.00K -635.00K -755.00K -167.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -29.53M -4.35M -76.51M -102.16M -110.49M